Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
621 to 640 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01DE029524 | Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer | 1 | 2024 |
| R01DK032493 | Natural History of Pre-Diabetic Autoimmunity (DAISY) | 1 | 2024 |
| R01DK042303 | Structural Biology of Complex Enzymes | 1 | 2024 |
| R01DK090262 | Regulation of Adipose Tissue Inflammation By Antigen Presenting Cells | 1 | 2024 |
| R01DK123233 | Creeping fat and Crohn's disease associated strictures | 1 | 2024 |
| R01DK124369 | Defining post-transcriptional regulons in intestinal epithelial regeneration | 1 | 2024 |
| R01DK128200 | Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis | 1 | 2024 |
| R01DK128907 | Characterization and functional assessment of a novel population of Wnt/beta-catenin driven adopocytes. | 1 | 2024 |
| R01DK129598 | Treating Kidney Injury by Modulating Heat Shock Proteins Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles | 1 | 2024 |
| R01EB030549 | Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification | 1 | 2024 |
| R01ES031253 | Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | 1 | 2024 |
| R01EY017006 | Control of Trabecular Meshwork Cytoskeleton | 1 | 2024 |
| R01EY031377 | Wnt5a, a New Diabetic Corneal Marker Related to Wound Healing | 1 | 2024 |
| R01EY031424 | Uncovering novel biological processes and pathogenic mechanisms for glaucoma | 1 | 2024 |
| R01HL084312 | Molecular Regulation of Atherosclerosis Regression - Renewal | 1 | 2024 |
| R01HL122596 | Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension | 1 | 2024 |
| R01HL127203 | The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis | 1 | 2024 |
| R01HL136143 | Mechanisms of host protection against pathogen-associated proteases in acute lung injury | 1 | 2024 |
| R01HL136664 | Targeting T cell glutamine metabolism in severe asthma | 1 | 2024 |
| R01HL151385 | Let-7b in Extracellular Vesicles Secreted by Bronchial Epithelial Cells Increases the Antibiotic Sensitivity of Pseudomonas | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=32